Tuberculosis remains an enormous burden to human health, even at the beginning of the 21st century. The situation is worsening in many countries, particularly due to the synergy with the HIV epidemic and the appearance of multi-drug resistant (MDR) or extensively-drug resistant (XDR) tuberculosis. The urgently needed development of new tools that can improve the diagnosis, prevention and/or therapy of tuberculosis and other major mycobacterial diseases depends largely on the progress made by basic and applied research.

The EMBO conference series "Tuberculosis 2012" is an international congress that provides a premium forum for the discussion and exchange of the recent advances of current research and novel trends related to tuberculosis, its causative agent Mycobacterium tuberculosis and related pathogenic mycobacteria. This international meeting to be held from September 11-15, 2012, will take place in the Conference centre (CIS) within the campus of the Institut Pasteur, which can host up to 500 conference delegates and is situated in the center of Paris, France.

The conference will be of interest to researchers, doctors, and representatives from industry with focus on the biology of pathogenic mycobacteria and their interaction with their hosts. Participation by students and scientists in the early stages of their careers is highly encouraged. Tuberculosis 2012 will provide abundant opportunities for networking and exchange of information between senior scientists and professionals, new investigators and students.

Scientific committee

Pedro ALZARI (IP, Paris), Clifton BARRY (NIAID, NIH, Bethesda), Roland BROSCH (IP, Paris), Stewart COLE (EPFL, Lausanne), Sabine EHRT (Cornell University, New York), Laurent FRAISSE (Sanofi-Aventis, Toulouse), Brigitte GICQUEL (IP, Paris), and Valerie MIZRAHI (MRC, University of Cape Town).

Organizing Committee

Pedro ALZARI (Paris), Marco BELLINZONI (Paris), Roland BROSCH (Paris), Carmen BUCHRIESER (Paris), Laleh MAJLESSI (Paris), and Ludovic TAILLEUX (Paris).